Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
127.50
-0.50 (-0.39%)
Jul 16, 2025, 4:00 PM - Market closed
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc.
| Country | United States |
| Founded | 2007 |
| IPO Date | May 3, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,246 |
| CEO | Timothy Herbert |
Contact Details
Address: 5500 Wayzata Blvd., Suite 1600 Golden Valley, Minnesota 55416 United States | |
| Phone | (844) 672-4357 |
| Website | inspiresleep.com |
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| Employer ID | 26-1377674 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Timothy P. Herbert | Founder, Chairman, Chief Executive Officer and President |
| Richard J. Buchholz | Chief Financial Officer |
| Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary |
| Randall A. Ban | Executive Vice President of Patient Access &Therapy Development |
| Carlton W. Weatherby | Chief Strategy and Growth Officer |
| Ezgi Yagci | Vice President of Investor Relations |
| Melissa J. Mann | Chief People Officer |
| John C. Rondoni | Chief Product and Innovation Officer |
| Ivan Lubogo | SVice President of Strategic Sales |
| Andreas Henke | Executive Vice President and MD of Europe |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 13, 2025 | 8-K | Current Report |
| May 30, 2025 | SD | Form - SD |
| May 19, 2025 | 144 | Filing |
| May 13, 2025 | SCHEDULE 13G | Filing |
| May 5, 2025 | 10-Q | Quarterly Report |
| May 5, 2025 | 8-K | Current Report |
| May 5, 2025 | 8-K | Current Report |
| May 2, 2025 | 144 | Filing |
| Apr 30, 2025 | SCHEDULE 13G/A | Filing |
| Mar 18, 2025 | ARS | Filing |